Comparison of Pharmacokinetic and Pharmacodynamic Profiles of G-Pump (Glucagon Infusion) vs. GlucaGen Delivered Subcutaneously to Subjects With Type 1 Diabetes (T1DM)
Phase of Trial: Phase II
Latest Information Update: 08 Aug 2016
At a glance
- Drugs Glucagon (Primary)
- Indications Hypoglycaemia
- Focus Pharmacodynamics; Pharmacokinetics
- Sponsors XERIS Pharmaceuticals
- 26 Oct 2015 Status changed from active, no longer recruiting to completed, according to ClinicalTrials.gov record.
- 12 Aug 2014 Planned End Date changed from 1 Jul 2014 to 1 Nov 2014 as reported by ClinicalTrials.gov record.
- 12 Aug 2014 Planned primary completion date changed from 1 Jun 2014 to 1 Aug 2014 as reported by ClinicalTrials.gov record.